Home / Sponsors / Eikon Therapeutics

Does Eikon Therapeutics sponsor H-1B visas?

Yes — Eikon Therapeutics is an active H-1B sponsor.
Eikon Therapeutics filed 29 Labor Condition Applications (the first step of an H-1B) from Oct 2024 to Jun 2026, 83% certified, covering 29 positions. USCIS approved 4 new and 3 continuing H-1B petitions in FY2021–23 (100% approval rate).
29LCA filings FY2025–26
$146,858median filed salary
$137,067–$170,373middle 50% salary range
3open US tech jobs

Open jobs at Eikon Therapeutics

H-1B filings by year

Fiscal yearLCA filings
FY2025 (Oct 2024–Sep 2025)14
FY2026 (Oct 2025–Jun 2026)15

USCIS H-1B petition approvals

Fiscal yearApprovals (new + continuing)
FY20211
FY20225
FY20231

Most common job titles filed

Job titleFilings
Senior Manager, Statistical Programming2
Biologist (Sr. Research Associate)2
Associate Director, Trial Master File Operations2
Engineer, Software1
Research Associate, Medicinal Chemistry1
Manager, Clin Trial Master File Admin1
Sr. Staff Engineer, Microscopy1
Assoc. Dir., Clinical Study Management1
Mgr, Clinical Trial1
Lead Veeva Vault Admin1

Where Eikon Therapeutics sponsors

WorksiteFilings
Jersey City, NJ14
Millbrae, CA7
Hayward, CA6
Los Angeles, CA1
Portland, OR1

Notes

Source: US Department of Labor OFLC LCA disclosure data (FY2025 and FY2026 Q1–Q3) and USCIS H-1B Employer Data Hub (FY2021–FY2023), matched by normalized employer name. An LCA is filed before an H-1B petition and doesn’t mean a visa was issued. Past filings don’t guarantee that a specific role will be sponsored. How we build these pages · Request a correction